These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 9412242)
21. Atenolol is dead: long live beta-blockade. Cockcroft JR J Am Coll Cardiol; 2009 Jun; 53(22):2102; author reply 2106-7. PubMed ID: 19477365 [No Abstract] [Full Text] [Related]
22. Beta-blockade in myocardial ischemia: new aspects in mechanisms and therapy. Symposium proceedings. Heidelberg, Federal Republic of Germany, January 31, 1987. J Cardiovasc Pharmacol; 1988; 12 Suppl 1():S1-105. PubMed ID: 2468828 [No Abstract] [Full Text] [Related]
23. Fifty years of beta-adrenergic blockade: a golden era in clinical medicine and molecular pharmacology. Frishman WH Am J Med; 2008 Nov; 121(11):933-4. PubMed ID: 18954835 [No Abstract] [Full Text] [Related]
24. [Current aspects of the use of beta-adrenergic blockaders]. Trifunović S; Pavlović K Med Pregl; 1984; 37(3-4):93-101. PubMed ID: 6149454 [No Abstract] [Full Text] [Related]
26. [Beta-adreno-blockers use in combination of cardiovascular and pulmonary diseases]. Makolkin VI; Ovcharenko SI; Litvinova IV Ter Arkh; 2008; 80(8):86-9. PubMed ID: 18807550 [No Abstract] [Full Text] [Related]
27. Beta-blockade--selection and use. Heikkilä J; Jounela A; Katila M; Luomanmäki K; Frick MH Ann Clin Res; 1979 Dec; 11(6):267-89. PubMed ID: 44825 [No Abstract] [Full Text] [Related]
31. The role of beta-blockers as a cornerstone of cardiovascular therapy. Hollenberg NK Am J Hypertens; 2005 Dec; 18(12 Pt 2):165S-168S. PubMed ID: 16373194 [TBL] [Abstract][Full Text] [Related]
33. The use of beta adrenergic blocking drugs in cardiovascular disease. Prichard BN Scott Med J; 1976 Oct; 21(4):182-7. PubMed ID: 11558 [No Abstract] [Full Text] [Related]
34. [Cardiovascular pharmacology (IV). The current validity of "old" drugs: beta-blockers]. Permanyer Miralda G; Sanz Girgas E Rev Esp Cardiol; 1994 Sep; 47(9):616-25. PubMed ID: 7973029 [No Abstract] [Full Text] [Related]
35. Beta-adrenergic blockade. An update. Frishman WH; Teicher M Cardiology; 1985; 72(5-6):280-96. PubMed ID: 2866839 [TBL] [Abstract][Full Text] [Related]
36. [Treatment of cardiovascular diseases with beta-blockers: the place of metoprolol and its various drug formulations]. Martsevich SIu Kardiologiia; 2003; 43(12):78-81. PubMed ID: 15035258 [No Abstract] [Full Text] [Related]
37. A symposium: primary and secondary prevention of cardiovascular disease. March 22, 1990, New Orleans, Louisiana. Proceedings. Am J Cardiol; 1990 Sep; 66(9):1C-55C. PubMed ID: 1977301 [No Abstract] [Full Text] [Related]
38. [Beta-adrenergic receptor blocking agents in cardiovascular diseases]. Kedra M Pol Arch Med Wewn; 1971 May; 46(5):525-33. PubMed ID: 4398057 [No Abstract] [Full Text] [Related]
39. [Beta blockers and cardiovascular risk in chronic obstructive pulmonary disease]. Machado-Alba JE; Medina-Morales DA; Bañol-Giraldo AM; Machado-Duque ME Rev Med Chil; 2014 Jun; 142(6):807-8. PubMed ID: 25327330 [No Abstract] [Full Text] [Related]
40. [Cardiology in the aged, the state of positions and perspectives]. Friocourt P; Cudennec T Soins Gerontol; 2009; (79):20-3. PubMed ID: 19813652 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]